Aankondiging • Mar 16
Tong Ren Tang Technologies Co. Ltd. to Report Fiscal Year 2025 Results on Mar 27, 2026 Tong Ren Tang Technologies Co. Ltd. announced that they will report fiscal year 2025 results on Mar 27, 2026 Aankondiging • Feb 06
Tong Ren Tang Technologies Co. Ltd. Announces Appointment of Mr. Siu, Paul Yu Hay as Independent Non-Executive Director and Changes in Board Committee Composition, Effective February 6, 2026 Tong Ren Tang Technologies Co. Ltd. announced that, following the extraordinary general meeting held on February 6, 2026, announced that, with effect from 6 February 2026, Mr. Siu, Paul Yu Hay has been appointed as an independent non-executive Director of the ninth session of the Board. The resignation of Mr. Li Siu Bun as an independent non-executive Director has also taken effect from the same date. Mr. Siu, Paul Yu Hay will enter into a director's service contract with the Company for a term commencing from the date of his appointment (i.e. 6 February 2026) and until the end of this session of the Board, subject to re-election at the end of the term. The resignation of Mr. Li Siu Bun as the chairman of the Audit Committee and a member of each of the Remuneration Committee and the Strategy and Planning Committee has also taken effect on 6 February 2026. The Board further resolved on 6 February 2026 to appoint Mr. Siu, Paul Yu Hay as the chairman of the Audit Committee, and a member of the Remuneration Committee and the Strategy and Planning Committee, all with effect from the same date. Aankondiging • Jan 14
Tong Ren Tang Technologies Co. Ltd. Announces Resignation of Li Siu Bun from the Positions as an Independent Non-Executive Director, Chairman of the Audit Committee of the Board and A Member of Each of the Remuneration Committee of the Board and the Strategy and Planning Committee On 13 January 2026, the board of directors of Tong Ren Tang Technologies Co. Ltd. received a resignation letter from Mr. Li Siu Bun, informing the Board of his resignation from the positions as an independent non-executive Director, chairman of the audit committee of the Board and a member of each of the remuneration committee of the Board and the strategy and planning committee of the Board due to work adjustments. The aforesaid resignation of Mr. Li will take effect upon the new independent non-executive Director being elected by the shareholders of the Company at the general meeting to be held in due course. Aankondiging • Dec 31
Tong Ren Tang Technologies Co. Ltd. Announces Board Changes Tong Ren Tang Technologies Co. Ltd. held an extraordinary general meeting on December 30, 2025, at which the appointment of Ms. Du Xin as a non-executive Director of the ninth session of the Board of the Company was approved and confirmed. The resignation of Mr. Chen Fei as a non-executive Director has also taken effect from the same date. Ms. Du Xin will enter into a director’s service contract with the Company for a term commencing from the date of her appointment, December 30, 2025, and until the end of this session of the Board, subject to re-election at the end of the term. Ms. Du Xin’s remuneration for her services as a non-executive Director is nil, which is determined by the Board with reference to the recommendation from the remuneration committee of the Board, having taken into account her duties and responsibilities with the Company and the prevailing market conditions. As at the date of this announcement, Ms. Du Xin’s biographical details remain unchanged from those stated in the circular dated December 1, 2025 save as disclosed in this announcement. As at the date of this announcement, the Board comprises Mr. Zhang Yi, Mr. Zhang Chun You, and Ms. Wen Kai Ting as executive Directors, Ms. Du Xin and Ms. Feng Li as non-executive Directors, Ms. Chan Ching Har, Eliza, Mr. Zhan Yuan Jing and Mr. Li Siu Bun as independent non-executive Directors, and Mr. Zhu Dong Sheng as employee Director. Aankondiging • Aug 15
Tong Ren Tang Technologies Co. Ltd. to Report First Half, 2025 Results on Aug 26, 2025 Tong Ren Tang Technologies Co. Ltd. announced that they will report first half, 2025 results on Aug 26, 2025 Aankondiging • May 20
Tong Ren Tang Technologies Co. Ltd., Annual General Meeting, Jun 12, 2025 Tong Ren Tang Technologies Co. Ltd., Annual General Meeting, Jun 12, 2025, at 13:30 China Standard Time. Location: no. 20 nansanhuan zhonglu, fengtai district, beijing, prc., China Aankondiging • Mar 13
Tong Ren Tang Technologies Co. Ltd. to Report Fiscal Year 2024 Results on Mar 28, 2025 Tong Ren Tang Technologies Co. Ltd. announced that they will report fiscal year 2024 results on Mar 28, 2025 Aankondiging • Oct 29
Tong Ren Tang Technologies Co. Ltd. Announces Resignation of Yung Mei Yee as Joint Company Secretary The board of directors of Tong Ren Tang Technologies Co. Ltd. announced that, due to work adjustment, Ms. Yung Mei Yee ("Ms. Yung") has resigned as the joint company secretary of the Company with effect from 29 October 2024. Ms. Yung has confirmed that she has no disagreement with the Board and there is no matter relating to her resignation that needs to be brought to the attention of the shareholders of the Company or The Stock Exchange of Hong Kong Limited. Following the resignation of Ms. Yung, Mr. Li Yijun, the other Joint Company Secretary, who possess the qualifications and experience of company secretary as required under Rule 3.28 of the Rules Governing the Listing of Securities on the Hong Kong Stock Exchange, will remain in office and act as the sole company secretary of the Company with effect from 29 October 2024. Aankondiging • Aug 15
Tong Ren Tang Technologies Co. Ltd. to Report First Half, 2024 Results on Aug 30, 2024 Tong Ren Tang Technologies Co. Ltd. announced that they will report first half, 2024 results on Aug 30, 2024 Aankondiging • May 22
Tong Ren Tang Technologies Co. Ltd., Annual General Meeting, Jun 12, 2024 Tong Ren Tang Technologies Co. Ltd., Annual General Meeting, Jun 12, 2024, at 09:30 China Standard Time. Location: no. 20 nansanhuan zhonglu, fengtai district, the prc, beijing China Aankondiging • Mar 13
Tong Ren Tang Technologies Co. Ltd. to Report Fiscal Year 2023 Results on Mar 22, 2024 Tong Ren Tang Technologies Co. Ltd. announced that they will report fiscal year 2023 results on Mar 22, 2024 Aankondiging • Mar 05
Tong Ren Tang Technologies Co. Ltd. Receives Notice of Approval for Clinical Trial of Medicine Tong Ren Tang Technologies Co. Ltd. announced that the pharmaceutical factory of the Company recently received the Notice of Approval for Clinical Trial of Medicine (Yao Wu Lin Chuang Shi Yan Pi Zhun Tong Zhi Shu) issued by the National Medical Products Administration. Details are as follows: Basic information of the medicine: Qishen Granules (Qi Can Ke Li) Applicant: Tong Ren Tang Technologies Co. Ltd.'s Pharmaceutical Factory. Category of registration: Registration category 1.1 of traditional Chinese medicines. Indications: Benefiting qi and warming yang, and promoting blood circulation and detoxication. Curing for the syndrome of chronic heart failure due to qi deficiency and blood stasis. Acceptance number: CXZL2300074. Notice number: 2024LP00491. Review conclusion: According to the Drug Administration Law of the People's Republic of China (<Zhong Hua Ren Min Gong He Guo Yao Pin Guan Li Fa >) /V Vaccine Administration Law of the People'sRepublic of China (Zhong Hua Ren Minong He Guo Yi Miao Guan Li Fa >) and relevant regulations, Qishen Granules (Qi Can Ke Li) was approved to use in clinical trial for chronic heart failure with reduced ejection fraction. Research and development of the medicine and related information. The Qishen Granules ("Qi Can Ke Li") applied for clinical trial by the pharmaceutical factory of the Company is a traditional Chinese medicine compound preparation, which is applied according to the registration category 1.1 of traditional Chinese medicines and is intended to be used for chronic heart failure syndrome of qi deficiency and bloodstasis. As at the date of this announcement, the Company has invested approximately RMB 7.8 million (unaudited) in the research and development of Qi Can Ke Li). Risk warning: In accordance with the requirements of the relevant laws and regulations on registration of medicine in the PRC, a clinical trial of medicine shall be performed upon receiving the approval for the clinical trial and the medicine shall be produced and marketed only upon being assessed and scrutinized by the National Medical Products Administration. Given its special nature and long cycle from clinical trials to production upon approval which involves many stages, the research and development of medicine are susceptible to many unpredictable factors. There are uncertainties in the progress and results of clinical trials and the future competitive landscape of the pharmaceutical market. Investors are advised to consider the risks involved and be cautious in making investment decisions. Aankondiging • Jan 30
Tong Ren Tang Technologies Co. Ltd. Provides Earnings Guidance for the Twelve Months Ended 31 December 2023 Tong Ren Tang Technologies Co. Ltd. provided earnings guidance for the twelve months ended 31 December 2023. For the period the Group is expected to range from a decrease by approximately 3% to an increase by approximately 7% as compared to the corresponding period of last year. Aankondiging • Jan 22
Tong Ren Tang Technologies Co. Ltd. Announces Board Changes The board (the "Board") of directors (the "Director(s)") of Tong Ren Tang Technologies Co. Ltd. announce that the extraordinary general meeting of the Company was held on 22 January 2024, approved the appointment of Mr. Di Shu Bing as an executive Director of the eighth session of the Board. Following the resignation of Mr. Gu Hai Ou as an executive Director, Mr. Di Shu Bing has been appointed as an executive Director of the eighth session of the Board of the Company as approved by the Shareholders at the EGM. The terms of office of Mr. Di Shu Bing commence from the date of appointment (i.e. 22 January 2024) and until the end of this session of the Board, subject to re-elected at the end of the term. Mr. Di Shu Bing will not receive remuneration for his service as an executive Director. The Board announce that the Board resolved on 22 January 2024 to elect Mr. Di Shu Bing as the Chairman of the Board. On the same day, the Board also resolved to appoint Mr. Di Shu Bing as the chairman of the nomination committee of the Board and the chairman of the strategy and planning committee of the Board. The Board hereby announces that, Mr. Di Shu Bing was appointed as an authorized representative of the Company under the Rule 3.05 of the Hong Kong Listing Rules with effect from 22 January 2024. Aankondiging • Dec 13
Tong Ren Tang Technologies Co. Ltd. Announces Resignation of Gu Hai Ou as Executive Director, Chairman of the Board, Chairman of the Nomination Committee, Chairman of the Strategy and Planning Committee On 13 December 2023, the board of directors of Tong Ren Tang Technologies Co. Ltd. received a resignation letter from Mr. Gu Hai Ou ("Mr. Gu"), informing the Board of his resignation from the positions as an executive Director, chairman of the Board, chairman of the nomination committee of the Board, chairman of the strategy and planning committee of the Board and the authorized representative, due to work adjustments. The above-mentioned resignation of Mr. Gu will take effect upon the new executive Director being elected by the shareholders of the Company (the "Shareholders") at the general meeting to be held. Mr. Gu has confirmed that he has no disagreement with the Board and there is no matter relating to his resignation that needs to be brought to the attention of the Stock Exchange and the Shareholders. The Board further announces on 13 December 2023, proposal in relation to the appointment of Mr. Di Shu Bing ("Mr. Di") as the executive Director of the eighth Board of Directors of the Company, and to have the Board recommend his remuneration and authorize the Board to enter into a service contract with him. The Board therefore proposed to appoint Mr. Di as an executive Director in accordance with relevant laws and regulations and the articles of association of the Company. The proposed appointment of Mr. Di as an executive Director is subject to the approval by the Shareholders at the general meeting. Mr. Di Shu Bing (), aged 49, a senior accountant with a master degree of public administration. Mr. Di previously served as the finance supervisor of Beijing Tong Ren Tang Medicinal Herbal Wine Branch, the deputy manager of Beijing Tong Ren Tang Medicinal Herbal Wine Branch, a member of the Party Committee and the deputy general manager of Beijing Tong Ren Tang Commercial Investment Group, the assistant to the general manager and head of economic operation department of China Beijing Tong Ren Tang Group Co. Ltd., a director of Beijing Tong Ren Tang Health Industry Investment Co. Ltd., the chairman of Beijing Tong Ren Tang Traditional Chinese Medicine Formula Granules Investment Co. Ltd., a director of Beijing Tong Ren Tang Biological Product Development Co. Ltd., a director of Beijing Tong Ren Tang Cosmetics Co. Ltd., the vice chairman of Beijing Entrepreneurs Association and the vice chairman of Beijing Enterprise Confederation, the deputy head of the finance department, the deputy head and head of the investment management department, the secretary of the Party Committee, a director and the general manager of Beijing Tong Ren Tang Company Limited. Mr. Di currently serves as party secretary of the CPC Committee and chairman of Beijing Tong Ren Tang Company Limited, the deputy general manager of China Beijing Tong Ren Tang Group Co. Ltd. and the vice chairman of Beijing Pharmaceutical Profession Association. Aankondiging • Aug 26
Tong Ren Tang Technologies Co. Ltd. Announces Board Changes Tong Ren Tang Technologies Co. Ltd. announced following the resignation of Mr. Wang Yu Wei as an executive director, Mr. Chen Jia Fu has been appointed as an executive director of the eighth session of the board of the company as approved by the Shareholders at the EGM. The terms of office of Mr. Chen Jia Fu commence from the date of appointment (that is 25 August 2023) and until the end of this session of the board, subject to re-elected at the end of the term. Mr. Chen Jia Fu will not receive remuneration for his service as an executive director. Change in board committee members: The board further announced that following the resignation of Mr. Wang Yu Wei as an executive Director, Mr. Chen Jia Fu has been appointed as a member of the strategy and planning committee of the board with effect from 25 August 2023. Aankondiging • Aug 04
Tong Ren Tang Technologies Co. Ltd. to Report First Half, 2023 Results on Aug 24, 2023 Tong Ren Tang Technologies Co. Ltd. announced that they will report first half, 2023 results on Aug 24, 2023 Aankondiging • Feb 17
Tong Ren Tang Technologies Co. Ltd. Announces Change of Director The board of directors of Tong Ren Tang Technologies Co. Ltd. announced that the extraordinary general meeting (the "EGM") of the Company was held at No. 20 Nansanhuan Zhonglu, Fengtai District, Beijing, the People's Republic of China (the "PRC") at 9:30 a.m., on 16 February 2023 approve the appointment of Ms. Wang Chun Rui as a non-executive Director of the eighth session of the Board of the Company and the remuneration proposed by the Board, and to authorize the Board to enter into the service contract with Ms. Wang Chun Rui. Following the resignation of Ms. Guo Ya Qing as a non-executive director, Ms. Wang Chun Rui has been appointed as a non-executive director of the eighth session of the Board of the Company as approved by the Shareholders at the EGM. The terms of office of Ms. Wang Chun Rui commence from the date of appointment (i.e. 16 February 2023) and until the end of this session of the Board, subject to re-elected at the end of the term. Ms. Wang Chun Rui will not receive remuneration for her service as a non-executive Director. 
